UNC-Chapel Hill Receives $65M from NIH for Antiviral Drug Development Center

Media Type
Article
Publish or Event Date
Research Institution
UNC Gillings School of Global Public Health
Short Title
UNC-Chapel Hill Receives $65M from NIH for Antiviral Drug Development Center
Content Coordinator
Content Manager

Notice of Special Interest (NOSI)— Climate Change and Health

Study—Medicine for Inflammatory Bowel Disease May Protect Against Severe COVID-19

In Less than 10 Minutes, Stanford Researchers Isolate the Rarest White Blood Cells

U of M Receives NIAID Grant to Develop Drug Treatments for Future Viral Pandemics

Scientists Part of International Study on Improving Vaccine Effectiveness

Remembrance of Viral Encounters Past

Publish or Event Date
Research Institution
Harvard Medical School
Short Title
Remembrance of Viral Encounters Past

Killer T vs. Memory – DNA Isn’t Destiny for T Cells

Publish or Event Date
Short Title
Killer T vs. Memory – DNA Isn’t Destiny for T Cells

UNC-Chapel Hill Receives $65M from NIH for Antiviral Drug Development Center

Bird Flu—How It’s Spreading and What to Know About This Outbreak